• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2020 Guidelines of the Polish Society of Laboratory Diagnostics (PSLD) and the Polish Lipid Association (PoLA) on laboratory diagnostics of lipid metabolism disorders.

作者信息

Solnica Bogdan, Sygitowicz Grażyna, Sitkiewicz Dariusz, Cybulska Barbara, Jóźwiak Jacek, Odrowąż-Sypniewska Grażyna, Banach Maciej

机构信息

Department of Clinical Biochemistry, Jagiellonian University Medical College, Krakow, Poland.

Department of Clinical Chemistry and Laboratory Diagnostics, Medical University of Warsaw, Warsaw, Poland.

出版信息

Arch Med Sci. 2020 Mar 2;16(2):237-252. doi: 10.5114/aoms.2020.93253. eCollection 2020.

DOI:10.5114/aoms.2020.93253
PMID:32190133
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7069434/
Abstract
摘要

相似文献

1
2020 Guidelines of the Polish Society of Laboratory Diagnostics (PSLD) and the Polish Lipid Association (PoLA) on laboratory diagnostics of lipid metabolism disorders.波兰实验室诊断学会（PSLD）和波兰脂质协会（PoLA）2020年脂质代谢紊乱实验室诊断指南。
Arch Med Sci. 2020 Mar 2;16(2):237-252. doi: 10.5114/aoms.2020.93253. eCollection 2020.
2
2024 Guidelines of the Polish Society of Laboratory Diagnostics and the Polish Lipid Association on laboratory diagnostics of lipid metabolism disorders.波兰实验室诊断学会和波兰脂质协会2024年脂质代谢紊乱实验室诊断指南。
Arch Med Sci. 2024 Mar 18;20(2):357-374. doi: 10.5114/aoms/186191. eCollection 2024.
3
PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021.2021年波兰脂质紊乱诊断与治疗的PoLA/CFPiP/PCS/PSLD/PSD/PSH指南
Arch Med Sci. 2021 Nov 8;17(6):1447-1547. doi: 10.5114/aoms/141941. eCollection 2021.
4
Diagnostics and Treatment of Thyroid Carcinoma.甲状腺癌的诊断与治疗
Endokrynol Pol. 2016;67(1):74-107. doi: 10.5603/EP.2016.0011.
5
Pharmacotherapy of pain in cancer patients - recommendations of the Polish Association for the Study of Pain, Polish Society of Palliative Medicine, Polish Society of Oncology, Polish Society of Family Medicine, Polish Society of Anaesthesiology and Intensive Therapy and Association of Polish Surgeons.癌症患者疼痛的药物治疗——波兰疼痛研究协会、波兰姑息医学学会、波兰肿瘤学会、波兰家庭医学学会、波兰麻醉学与重症治疗学会以及波兰外科医生协会的建议
Pol Przegl Chir. 2018 Aug 31;90(4):55-84. doi: 10.5604/01.3001.0012.2904.
6
Polish Code of Ethics of a Medical Laboratory Specialist.波兰医学检验专家伦理准则。
EJIFCC. 2014 Sep 4;25(2):199-206. eCollection 2014 Sep.
7
PslD is a secreted protein required for biofilm formation by Pseudomonas aeruginosa.PslD是铜绿假单胞菌形成生物膜所需的一种分泌蛋白。
Appl Environ Microbiol. 2006 Apr;72(4):3066-8. doi: 10.1128/AEM.72.4.3066-3068.2006.
8
[Tick-borne diseases in Poland: Prevalence and difficulties in diagnostics].[波兰的蜱传疾病：患病率及诊断难点]
Med Pr. 2016;67(1):73-87. doi: 10.13075/mp.5893.00264.
9
Management of familial hypercholesterolemia in children and adolescents. Position paper of the Polish Lipid Expert Forum.儿童和青少年家族性高胆固醇血症的管理。波兰脂质专家论坛的立场文件。
J Clin Lipidol. 2014 Mar-Apr;8(2):173-80. doi: 10.1016/j.jacl.2014.01.001. Epub 2014 Jan 18.
10
Treatment guidelines for Circadian Rhythm Sleep - Wake Disorders of the Polish Sleep Research Society and the Section of Biological Psychiatry of the Polish Psychiatric Association. Part II. Diagnosis and treatment.波兰睡眠研究学会与波兰精神病学协会生物精神病学分会昼夜节律性睡眠-觉醒障碍治疗指南。第二部分。诊断与治疗。
Psychiatr Pol. 2017 Oct 29;51(5):815-832. doi: 10.12740/PP/68918.

引用本文的文献

1
Influence of Sex and Cardiometabolic Risk Factors on the High-Sensitivity Cardiac Troponins at the Concentrations Used as the Thresholds for Cardiovascular Risk Stratification in a Presumably Healthy Polish Population.性别和心血管代谢危险因素对波兰健康人群中心血管风险分层阈值浓度下高敏心肌肌钙蛋白的影响
J Clin Med. 2024 Nov 25;13(23):7126. doi: 10.3390/jcm13237126.
2
Effects of Increasing Farmed Salmon Intake to the Recommended Fish-Intake Amounts on Lipid Profile in Young Women: An 8-Week Intervention Study.将养殖三文鱼摄入量增加至推荐鱼类摄入量对年轻女性血脂水平的影响：一项为期8周的干预研究。
Nutrients. 2024 Nov 26;16(23):4051. doi: 10.3390/nu16234051.
3

本文引用的文献

1
Statins and Lp(a): do not make perfect the enemy of excellent.他汀类药物与脂蛋白(a)：勿让完美成为卓越之敌。
Eur Heart J. 2020 Jan 1;41(1):190-191. doi: 10.1093/eurheartj/ehz775.
2
Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM.定量动脉粥样硬化脂蛋白用于降脂策略：EAS 和 EFLM 的基于共识的建议。
Clin Chem Lab Med. 2020 Mar 26;58(4):496-517. doi: 10.1515/cclm-2019-1253.
3
Characterization of lipoprotein profiles in patients with hypertriglyceridemic Fredrickson-Levy and Lees dyslipidemia phenotypes: the Very Large Database of Lipids Studies 6 and 7.
Application of Human Plasma Targeted Lipidomics and Analysis of Toxic Elements to Capture the Metabolic Complexities of Hypothyroidism.
应用人血浆靶向脂质组学和毒元素分析捕捉甲状腺功能减退症的代谢复杂性。
Molecules. 2024 Oct 31;29(21):5169. doi: 10.3390/molecules29215169.
4
Evaluation of miRNA-27a/b expression in patients with familial hypercholesterolemia.家族性高胆固醇血症患者中miRNA-27a/b表达的评估。
Arch Med Sci. 2022 May 29;20(4):1314-1320. doi: 10.5114/aoms/150500. eCollection 2024.
5
Bariatric Surgery and Metabolic Status.减重手术与代谢状态。
Medicina (Kaunas). 2024 Sep 20;60(9):1532. doi: 10.3390/medicina60091532.
6
Gray-Scale Median in Patients with Symptomatic and Asymptomatic Carotid Atherosclerosis-Risk Factors and Diagnostic Potential.有症状和无症状颈动脉粥样硬化患者的灰度中位数——危险因素及诊断潜力
Biomedicines. 2024 Jul 17;12(7):1594. doi: 10.3390/biomedicines12071594.
7
Food addiction and the physical and mental health status of adults with overweight and obesity.食物成瘾与超重和肥胖成年人的身心健康状况。
PeerJ. 2024 Jun 28;12:e17639. doi: 10.7717/peerj.17639. eCollection 2024.
8
2024 Guidelines of the Polish Society of Laboratory Diagnostics and the Polish Lipid Association on laboratory diagnostics of lipid metabolism disorders.波兰实验室诊断学会和波兰脂质协会2024年脂质代谢紊乱实验室诊断指南。
Arch Med Sci. 2024 Mar 18;20(2):357-374. doi: 10.5114/aoms/186191. eCollection 2024.
9
Fractional Flow Reserve-Based Patient Risk Classification.基于血流储备分数的患者风险分类。
Diagnostics (Basel). 2023 Oct 31;13(21):3349. doi: 10.3390/diagnostics13213349.
10
Reporting LDL cholesterol results by clinical biochemistry laboratories in Czechia and Slovakia to improve the detection rate of familial hypercholesterolemia.捷克共和国和斯洛伐克临床生物化学实验室报告 LDL 胆固醇结果以提高家族性高胆固醇血症的检出率。
Biochem Med (Zagreb). 2023 Oct 15;33(3):030705. doi: 10.11613/BM.2023.030705.
高甘油三酯血症弗雷德里克森-利维及李斯血脂异常表型患者的脂蛋白谱特征：脂质研究大型数据库6和7
Arch Med Sci. 2019 Sep;15(5):1195-1202. doi: 10.5114/aoms.2019.87207. Epub 2019 Aug 22.
4
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.2019年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南：通过血脂修饰降低心血管风险
Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455.
5
National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries.国家胆固醇总量趋势掩盖了高密度脂蛋白胆固醇和非高密度脂蛋白胆固醇以及总胆固醇与高密度脂蛋白胆固醇比值的异质性变化：亚洲和西方国家 458 项基于人群的研究的汇总分析。
Int J Epidemiol. 2020 Feb 1;49(1):173-192. doi: 10.1093/ije/dyz099.
6
Comparing different assessments of remnant lipoprotein cholesterol: The very large database of lipids.比较脂蛋白胆固醇残留的不同评估方法：非常大的脂质数据库。
J Clin Lipidol. 2019 Jul-Aug;13(4):634-644. doi: 10.1016/j.jacl.2019.06.001. Epub 2019 Jun 11.
7
Analytical methods for cholesterol quantification.胆固醇定量分析方法。
J Food Drug Anal. 2019 Apr;27(2):375-386. doi: 10.1016/j.jfda.2018.09.001. Epub 2018 Oct 4.
8
Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score".家族性乳糜微粒血症综合征（FCS）患者的识别和诊断：专家小组建议和“FCS 评分”提案。
Atherosclerosis. 2018 Aug;275:265-272. doi: 10.1016/j.atherosclerosis.2018.06.814. Epub 2018 Jun 18.
9
Cholesterol Subfraction Analysis in Patients with Acute Coronary Syndrome.急性冠状动脉综合征患者的胆固醇亚组份分析。
Curr Vasc Pharmacol. 2019;17(4):365-375. doi: 10.2174/1570161116666180601083225.
10
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM.量化动脉粥样硬化脂蛋白：个体化医学和极低 LDL 胆固醇浓度时代的当前和未来挑战。EAS 和 EFLM 的共识声明。
Clin Chem. 2018 Jul;64(7):1006-1033. doi: 10.1373/clinchem.2018.287037. Epub 2018 May 14.